# Iceni Diagnostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/iceni-diagnostics

- Industry: Healthcare
- Headquarters: Norwich, UK
- Website: www.icenidiagnostics.com
- Total disclosed funding: $1.1M
- Latest round: Seed (Dec 11, 2020)
- Investors on record: 1

## About

Iceni Diagnostics Ltd is a diagnostic solutions company focused on improving patient care through innovative technologies. Their offerings enable healthcare professionals to enhance disease management and decision-making in clinical settings.Founded in 2014 and headquartered in Norwich, UK, Iceni Diagnostics Ltd specializes in advanced diagnostic solutions. The company was co-founded by David Russell, and its CEO is Martin Stocks. The firm has secured funding in a SEED round in December 2020, raising GBP 822,000 from Anglia Capital Group and other investors, valuing the company at GBP 10.38 million post-money. The company has completed 1 deal, with its most recent deal date being December 11, 2020.Iceni Diagnostics specializes in innovative diagnostic solutions aimed at enhancing patient care and facilitating efficient disease management. Their core offerings include advanced diagnostic kits designed to detect specific biomarkers associated with various medical conditions, enabling healthcare professionals to make informed decisions. These products are engineered for accuracy and reliability, addressing critical use cases in clinical settings, including early disease detection and treatment monitoring. The primary customer base consists of hospitals, laboratories, and healthcare providers across North America and Europe, essential for effective patient management. The company’s technology focuses on providing actionable insights to improve patient outcomes and streamline clinical workflows.Iceni Diagnostics generates revenue through a structured model of B2B transactions, primarily involving partnerships with healthcare providers and laboratories. Their revenue streams are anchored in the sale of its flagship diagnostic products, offered through subscription agreements and direct sales channels. Regular transactions occur as healthcare facilities place bulk orders for diagnostic kits, ensuring a steady supply for ongoing needs. Their pricing structure is tiered based on volume, reflecting the scale of each client’s requirements, which fosters long-term partnerships and secures consistent revenue.Iceni Diagnostics plans to leverage its recent SEED funding of GBP 822,000 raised in December 2020 to support the launch of new diagnostic products and expand into new markets. The company aims to introduce additional diagnostic solutions by 2023, targeting growth within the healthcare sectors of Europe and North America. The recent funding will facilitate the development of these products and enhance marketing efforts to penetrate these strategic markets.

## Funding rounds

- Seed, Dec 11, 2020, $1.1M — Anglia Capital Group

## Investors

- Anglia Capital Group (https://capitalatlas.ai/funds/anglia-capital-group) — Seed